Fundraising FoxIkena Oncology, Inc.
Boston, US · Delaware corporation · 6 known investors
Find your way into Ikena Oncology, Inc.
Sign up to see every warm intro you have to Ikena Oncology, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ikena Oncology, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JM
Jotin MarangoExecutive
MM
Mark ManfrediExecutive
JE
Jeffrey EcsedyExecutive
SS
Sergio SantillanaExecutiveMedical oncologist with over 30 years of career experience, including more than 10 years of clinical practice and 22+ years in oncology drug development at major pharmaceutical and biotechnology companies. He has led development of targeted and immuno-oncology therapies across multiple modalities, and served as Chief Medical Officer at four biotechnology firms, with regulatory approvals obtained for three targeted agents in the US, EU, Japan, and other major markets.
MZ
Michelle ZhangExecutive
Board
OS
JF
ID
DB
RW
Richard WoosterBoard director
OH
Owen HughesBoard director
MK
Maria KoehlerBoard director
Investors · 6
Atlas VentureinferredCambridge · $500K – $1Mvia Jean-François Formela · board
How we know: board seat on SEC Form D · Not right? Tell us
Biotechnology Value FundreportedSan Francisco
How we know: funding news · Not right? Tell us
Foresite CapitalreportedWest Hollywood
How we know: funding news · Not right? Tell us
OrbiMedinferredNew York · $1M – $75Mvia David Bonita · board
How we know: board seat on SEC Form D · Not right? Tell us
RTW Investments L.P.reportedNew York
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$42.6M disclosed across 1 of 3 rounds · 2023–2025
▶$75MofferedJul 2025 · BiotechnologyRule 506(b)
▶$75MofferedJul 2025 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard WoosterDirector
- Otello StampacchiaDirector
- Jotin MarangoExecutive Officer
- Jean-Francois FormelaDirector
- Mark ManfrediExecutive Officer, Director
- Jeffrey EcsedyExecutive Officer
- Owen HughesDirector
- Iain DukesDirector
- Maria KoehlerDirector
- David BonitaDirector
- Offering amount
- $75M
- Placement agents
- LEERINK PARTNERS LLC
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$42.6MraisedAug 2023 · 48 investors · PharmaceuticalsRule 506(b)
▶$42.6MraisedAug 2023 · 48 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Maria KoehlerDirector
- Sergio SantillanaExecutive Officer
- Richard WoosterDirector
- Michelle ZhangExecutive Officer
- Jotin MarangoExecutive Officer
- Jeffrey EcsedyExecutive Officer
- Iain D. DukesDirector
- Owen HughesDirector
- Mark ManfrediExecutive Officer, Director
- Otello StampacchiaDirector
- Jean-Francois FormelaDirector
- David BonitaDirector
- Offering amount
- $42.6M
- Amount sold
- $42.6M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Ikena Oncology, Inc. went on to found or lead other companies.
Frequently asked questions
- Who are Ikena Oncology, Inc.'s investors?
- Ikena Oncology, Inc.'s investors include Atlas Venture, Biotechnology Value Fund, Foresite Capital, Omega Funds, OrbiMed, RTW Investments L.P..
- How much funding has Ikena Oncology, Inc. raised?
- Ikena Oncology, Inc. has disclosed $42.6M raised across 1 of its 3 known rounds.
- Where is Ikena Oncology, Inc. headquartered?
- Ikena Oncology, Inc. is headquartered in Boston, US.